Christopher J. Velis of Miraki Innovation to Deliver Keynote “The Next Quantum Leaps in Medtech” at LSI Emerging Medtech Summit 2020

This event is drawing attendance from active medtech investors, strategic buyers and the innovators building the future of healthcare.

LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Christopher J. Velis, Chairman of Miraki Innovation and Co-Founder of Auris Health (acquired by J&J for $5.7B) will deliver the keynote address at the Life Science Intelligence (LSI) Emerging Medtech Summit February 18-20^th, 2020 at The Ritz-Carlton in Laguna Niguel, CA.

In his keynote, “The Next Quantum Leaps in Medtech,” Velis will share his insights on a repeatable process for quantum leaps of innovation. He’ll discuss his experiences building companies such as Auris Health and he’ll provide both an investor's and innovator's perspective on the future of medtech.

The event is drawing attendance from major medtech investors and strategics looking to partner with new medical device, diagnostic, digital health and other healthtech innovators.

In addition to Velis’ keynote, the event will include over 100 startup CEO presentations, and lively panel discussions with venture capitalists, large corporates, and industry thought leaders.

A full agenda and list of attendees is here.

Investors attending include: JJDC, Sante Ventures, Connecticut Innovations, US Venture Partners, NEA, Pangaea Ventures, SV Health Investors, Miraki Innovation Fund, MVM Partners, Evonik VC, Sands Capital, Mayo Clinic Ventures, HealthTech Capital, Grey Sky Venture Partners, and more.

Strategics attending include: J&J, Medtronic, Boston Scientific, Abbott, Stryker, Edwards Lifesciences, Terumo, Fresenius, Intuitive Surgical, BD, W.L. Gore, and more.

About Life Science Intelligence (LSI)

LSI is a medical technology focused market intelligence & consulting company. We help medtech executives make informed strategic decisions by better understanding market dynamics, trends, opportunities and the competitive landscape.